Compare Moderna, Inc. (MRNA) vs Financial Select Sector SPDR Fund (XLF) Price & Performance

Moderna, Inc.Trade

Financial Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Financial Select Sector SPDR Fund — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while Financial Select Sector SPDR Fund trades at $56.07. The key difference: Financial Select Sector SPDR Fund is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.

	MRNA	XLF
Market Cap	$23.60B	—
Sector	Health	—
52-Week High	$81.80	$56.75
52-Week Low	$22.36	$47.80
Enterprise Value	$19.70B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 13 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

XLF

John Hancock Financial Opportunities Fund offers 6.5% growing dividend, beating S&P 500 and financial ETFs.Forbes · 14 hours agoBullish View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About Financial Select Sector SPDR Fund

The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.